Free-breathing 3D cardiac extracellular volume (ECV) mapping using a linear tangent space alignment (LTSA) model
- PMID: 39402014
- PMCID: PMC11606777
- DOI: 10.1002/mrm.30284
Free-breathing 3D cardiac extracellular volume (ECV) mapping using a linear tangent space alignment (LTSA) model
Abstract
Purpose: To develop a new method for free-breathing 3D extracellular volume (ECV) mapping of the whole heart at 3 T.
Methods: A free-breathing 3D cardiac ECV mapping method was developed at 3 T. T1 mapping was performed before and after contrast agent injection using a free-breathing electrocardiogram-gated inversion recovery sequence with spoiled gradient echo readout. A linear tangent space alignment model-based method was used to reconstruct high-frame-rate dynamic images from (k,t)-space data sparsely sampled along a random stack-of-stars trajectory. Joint T1 and transmit B1 estimation were performed voxel-by-voxel for pre- and post-contrast T1 mapping. To account for the time-varying T1 after contrast agent injection, a linearly time-varying T1 model was introduced for post-contrast T1 mapping. ECV maps were generated by aligning pre- and post-contrast T1 maps through affine transformation.
Results: The feasibility of the proposed method was demonstrated using in vivo studies with six healthy volunteers at 3 T. We obtained 3D ECV maps at a spatial resolution of 1.9 × 1.9 × 4.5 mm3 and a FOV of 308 × 308 × 144 mm3, with a scan time of 10.1 ± 1.4 and 10.6 ± 1.6 min before and after contrast agent injection, respectively. The ECV maps and the pre- and post-contrast T1 maps obtained by the proposed method were in good agreement with the 2D MOLLI method both qualitatively and quantitatively.
Conclusion: The proposed method allows for free-breathing 3D ECV mapping of the whole heart within a practically feasible imaging time. The estimated ECV values from the proposed method were comparable to those from the existing method.
Keywords: cardiac T1 mapping; cardiac extracellular volume (ECV) mapping; linear tangent space alignment (LTSA); manifold learning.
© 2024 International Society for Magnetic Resonance in Medicine.
Update of
-
Free-breathing 3D cardiac extracellular volume (ECV) mapping using a linear tangent space alignment (LTSA) model.ArXiv [Preprint]. 2024 Aug 22:arXiv:2408.12706v1. ArXiv. 2024. Update in: Magn Reson Med. 2025 Feb;93(2):536-549. doi: 10.1002/mrm.30284. PMID: 39253635 Free PMC article. Updated. Preprint.
Similar articles
-
Free-breathing 3D cardiac extracellular volume (ECV) mapping using a linear tangent space alignment (LTSA) model.ArXiv [Preprint]. 2024 Aug 22:arXiv:2408.12706v1. ArXiv. 2024. Update in: Magn Reson Med. 2025 Feb;93(2):536-549. doi: 10.1002/mrm.30284. PMID: 39253635 Free PMC article. Updated. Preprint.
-
Free-breathing 3D cardiac T1 mapping with transmit B1 correction at 3T.Magn Reson Med. 2022 Apr;87(4):1832-1845. doi: 10.1002/mrm.29097. Epub 2021 Nov 23. Magn Reson Med. 2022. PMID: 34812547 Free PMC article.
-
Free-breathing post-contrast three-dimensional T1 mapping: Volumetric assessment of myocardial T1 values.Magn Reson Med. 2015 Jan;73(1):214-22. doi: 10.1002/mrm.25124. Epub 2014 Feb 5. Magn Reson Med. 2015. PMID: 24554395 Free PMC article.
-
Free-breathing, non-ECG, continuous myocardial T1 mapping with cardiovascular magnetic resonance multitasking.Magn Reson Med. 2019 Apr;81(4):2450-2463. doi: 10.1002/mrm.27574. Epub 2018 Nov 19. Magn Reson Med. 2019. PMID: 30450749 Free PMC article.
-
Free-Breathing Ungated Radial Simultaneous Multi-Slice Cardiac T1 Mapping.J Magn Reson Imaging. 2025 Jun;61(6):2587-2600. doi: 10.1002/jmri.29676. Epub 2024 Dec 11. J Magn Reson Imaging. 2025. PMID: 39661447 Free PMC article.
Cited by
-
In vivo 3D myocardial membrane potential mapping in humans using PET/MRI.EJNMMI Res. 2025 Jul 26;15(1):93. doi: 10.1186/s13550-025-01287-7. EJNMMI Res. 2025. PMID: 40715686 Free PMC article.
References
-
- Schelbert EB, Messroghli DR. State of the art: clinical applications of cardiac T1 mapping. Radiology 2016;278(3):658–676. - PubMed
-
- Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, Mascherbauer J, Nezafat R, Salerno M, Schelbert EB. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). Journal of Cardiovascular Magnetic Resonance 2016;19(1):75. - PMC - PubMed
-
- Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Zumbo G, Knight DS, Kotecha T, Francis R, Hutt DF, Rezk T. Magnetic resonance in transthyretin cardiac amyloidosis. Journal of the American College of Cardiology 2017;70(4):466–477. - PubMed
MeSH terms
Substances
Grants and funding
- R01 EB035093/EB/NIBIB NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- R01HL137230/National Institutes of Health (NIH)
- R01 HL137230/HL/NHLBI NIH HHS/United States
- T32EB013180/National Institutes of Health (NIH)
- R01CA165221/National Institutes of Health (NIH)
- P41EB022544/National Institutes of Health (NIH)
- R01EB035093/National Institutes of Health (NIH)
- T32 EB013180/EB/NIBIB NIH HHS/United States
- P41 EB022544/EB/NIBIB NIH HHS/United States
- R01 EB033582/EB/NIBIB NIH HHS/United States
- K01 EB030045/EB/NIBIB NIH HHS/United States
- R01 CA165221/CA/NCI NIH HHS/United States
- R01EB033582/National Institutes of Health (NIH)
- K01EB030045/National Institutes of Health (NIH)
LinkOut - more resources
Full Text Sources